Emx2 expression in caudal forebrain primordium at E8.5, dorsal telencephalon at E9.5-10.5 and cortical ventricular zone later than E12.5. Otx, Tcf, Smad and two sites for unknown transcriptional factors are essential to all these activities. The enhancer is well conserved among tetrapods. The mutant that lacks this enhancer demonstrated that the Emx2 expression under this enhancer is indeed essential to diencephalon, telencephalon and cortical development. However, the Emx2 expression is greatly reduced, but present in the enhancer mutant, indicating the presence of another enhancer. The FB enhancer lacks the activity in cortical hem and does not exhibit a graded activity in dorsal telencephalon. These are unique features of the Emx2 expression in mammalian telencephalon that has Cajal-Retzius cells for the layer formation and exhibits area patterning; the second enhancer is most probably unique to mammal. results in re-activation of TESCO activity in the ovary, but not until after birth. This effect is similar to that seen for the endogenous Sox9 gene, implying that the latter occurs via the TESCO S178 M E C H A N I S M S O F D E V E L O P M E N T 1 2 6 ( 2 0 0 9 ) S 1 5 1 -S 1 8 1
tional factors are essential to all these activities. The enhancer is well conserved among tetrapods. The mutant that lacks this enhancer demonstrated that the Emx2 expression under this enhancer is indeed essential to diencephalon, telencephalon and cortical development. However, the Emx2 expression is greatly reduced, but present in the enhancer mutant, indicating the presence of another enhancer. The FB enhancer lacks the activity in cortical hem and does not exhibit a graded activity in dorsal telencephalon. These are unique features of the Emx2 expression in mammalian telencephalon that has Cajal-Retzius cells for the layer formation and exhibits area patterning; the second enhancer is most probably unique to mammal. 
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FOXL2 is able to repress the testis specific enhancer of SOX9 Susanne Jakob, Ryohei Sekido, Robin Lovell-Badge MRC National Institute for Medical Research, London, United Kingdom FOXL2 is a forkhead transcription factor, which, during gonad development, is exclusively expressed in the female supporting lineage from 12.5 dpc. In mice, homozygous mutations of Foxl2 lead to infertile females displaying ovarian failure with up-regulation of Sox9 and other testis-specific genes in the supporting cells of postnatal ovaries. For normal ovarian development it is essential that Sox9 becomes down-regulated in the XX gonad around 11.5 dpc and is kept in a suppressed status throughout life. It has been shown that a 1.4 kb enhancer element (TESCO) is sufficient to regulate Sox9 expression specifically in the testis. The fact that Foxl2 only becomes expressed after 12.5 dpc in the ovary, suggests that it might not be involved in the initial downregulation of Sox9, but plays a role in maintaining its active suppression.
Our data shows that FOXL2 can repress TESCO activation invitro. This repression is aggravated by estrogen receptor alpha.
Mutation of forkhead factor binding sites (FOX) in TESCO did not abolish the repression effect, but simultaneous mutation of FOX sites and estrogen response elements resulted in a loss of the enhanced effect mediated by ERa. Homozygous loss of Foxl2 results in re-activation of TESCO activity in the ovary, but not until after birth. This effect is similar to that seen for the endogenous Sox9 gene, implying that the latter occurs via the TESCO S178
